Researchers found that PCa patients who walked at a faster pace were more likely to have healthier blood vessels.
Researchers conducted a study in Iceland that found an association between prostate cancer risk and quality of sleep.
A new study is suggesting there is substantial geographic variation in deceased donor kidney waiting times.
Researchers have developed a personalized tool that can predict the likelihood of prostate cancer overdiagnosis.
A new product known as BL-9020 is being developed by Israeli researchers.
This year, several studies have suggested some foods and beverages may be highly beneficial to men with prostate cancer.
Levels of bisphenol A in components of dialysis machines may be toxic to immune cells circulating in hemodialysis patients.
An investigational new agent called tasquinimod may help increase survival in men with metastatic prostate cancer.
A new systematic literature review has found that it may not be cost-effective to provide primary screening for CKD in the general population.
Phase 3 studies assessing XIAFLEX show this agent may significantly improve quality of life.